Dishman Carbogen Amcis

Dishman Carbogen Amcis Limited, or 'imdcal', epitomises excellence in Contract Research and Manufacturing Services (CRAMS), serving the global pharmaceutical and bio-technology industries. The company aims to be the preferred partner for customers to create a better world by developing and manufacturing complex substances and highly potent active ingredients. Its fundamental purpose is to support and assist people worldwide suffering from illness, ensuring that this help is delivered efficiently, comprehensively, and effectively. The company's integrated CRAMS offerings cover the entire drug development lifecycle, from process research and development to late-stage clinical and commercial manufacturing. Through proactive partnerships, it anticipates client needs and is driven by a mission to inspire science and revolutionize healthcare across the globe with high-value solutions. With a workforce of over 2,200 members and a footprint across India, Switzerland, the UK, France, and China, it exemplifies innovation and reliability.;